Schedule 13G ownership disclosure

ENDOCYTE INC

Security class unavailable · CUSIP: 29269A102

Event date: 2017-09-29

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
2,722,000
Percent of class
6.4000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000897069-17-000500
Form type
SC 13G
Filer
Cambridge Isotope Laboratories, Inc.
CIK
CIK 1719422
Filed
Oct 12, 2017
Reporting period
Sep 29, 2017
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub